Chapter title |
β-Arrestins and G Protein-Coupled Receptor Trafficking.
|
---|---|
Chapter number | 9 |
Book title |
Arrestins - Pharmacology and Therapeutic Potential
|
Published in |
Handbook of experimental pharmacology, January 2014
|
DOI | 10.1007/978-3-642-41199-1_9 |
Pubmed ID | |
Book ISBNs |
978-3-64-241198-4, 978-3-64-241199-1
|
Authors |
Xufan Tian, Dong Soo Kang, Jeffrey L Benovic, Jeffrey L. Benovic, Tian, Xufan, Kang, Dong Soo, Benovic, Jeffrey L. |
Abstract |
Nonvisual arrestins (β-arrestin-1 and β-arrestin-2) are adaptor proteins that function to regulate G protein-coupled receptor (GPCR) signaling and trafficking. β-arrestins are ubiquitously expressed and function to inhibit GPCR/G protein coupling, a process called desensitization, and promote GPCR trafficking and arrestin-mediated signaling. β-arrestin-mediated endocytosis of GPCRs requires the coordinated interaction of β-arrestins with clathrin, adaptor protein 2 (AP2), and phosphoinositides. These interactions are facilitated by a conformational change in β-arrestin that is thought to occur upon binding to a phosphorylated activated GPCR. In this review, we provide an overview of the key interactions involved in β-arrestin-mediated trafficking of GPCRs. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 168 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 43 | 26% |
Student > Master | 25 | 15% |
Student > Bachelor | 17 | 10% |
Researcher | 12 | 7% |
Student > Doctoral Student | 10 | 6% |
Other | 15 | 9% |
Unknown | 46 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 40 | 24% |
Agricultural and Biological Sciences | 25 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 22 | 13% |
Medicine and Dentistry | 9 | 5% |
Chemistry | 7 | 4% |
Other | 15 | 9% |
Unknown | 50 | 30% |